FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ernest Kohorn

Research Profile

Disorders

Physiology

Pregnancy

Chemicals & Drugs

Concepts & Ideas

Procedures

Occupations

Gynecology

Co-author Network

Publications

TOP 3
Hextan Y S Ngan; Shigeru Sasaki; Michael J Seckl; Laurence A Cole; Seung J Kim; Ernest I Kohorn; Robert J Kurman; John R Lurain; John T Soper
Trophoblastic disease.
Ernest I Kohorn
Imaging practices in the diagnosis and management of gestational trophoblastic disease: an assessment.
Rebecca McCaffrey; Mert Bahtiyar; Ernest I Kohorn; Joseph T Chambers; Peter E Schwartz; Setsuko K Chambers
Neoadjuvant and adjuvant chemotherapy of cervical cancer: mature results of the phase 2 PBM-PFU protocol.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ernest Kohorn (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Hextan Y S Ngan; Shigeru Sasaki; Michael J Seckl; Laurence A Cole; Seung J Kim; Ernest I Kohorn; Robert J Kurman; John R Lurain; John T Soper
Trophoblastic disease.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2012;119 Suppl 2():S130-6.
2012: Ernest I Kohorn
Imaging practices in the diagnosis and management of gestational trophoblastic disease: an assessment.
The Journal of reproductive medicine 2012;57(5-6):207-10.
2011: Rebecca McCaffrey; Mert Bahtiyar; Ernest I Kohorn; Joseph T Chambers; Peter E Schwartz; Setsuko K Chambers
Neoadjuvant and adjuvant chemotherapy of cervical cancer: mature results of the phase 2 PBM-PFU protocol.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2011;21(3):535-44.
2010: Ernest I Kohorn
Letter to the editor with comments on article by Cole and Muller entitled "Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases".
Gynecologic oncology 2010;117(3):505.
2009: Ernest I Kohorn
Long-term outcome of placental-site trophoblastic tumours.
Lancet 2009;374(9683):6-7.
2009: Ernest I Kohorn
John McLean Morris: a career in surgery, gynecology and reproductive physiology.
Connecticut medicine 2009;73(4):223-7.
2008: Laurence A Cole; Sarah A Khanlian; Ernest I Kohorn
Evolution of the human brain, chorionic gonadotropin and hemochorial implantation of the placenta: insights into origins of pregnancy failures, preeclampsia and choriocarcinoma.
The Journal of reproductive medicine 2008;53(8):549-57.
2007: Ernest I Kohorn
Dynamic staging and risk factor scoring for gestational trophoblastic disease.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2007;17(5):1124-30.
2007: Ernest I Kohorn
Regional centers for trophoblastic disease.
American journal of obstetrics and gynecology 2007;196(2):95-6.
2006: Ernest I Kohorn
Presidential address. XIIIth World Congress on Gestational Trophoblastic Disease, Hong Kong, October 23-26, 2005.
The Journal of reproductive medicine 2006;51(10):855-6.
2006: Laurence A Cole; Ernest I Kohorn
The need for an hCG assay that appropriately detects trophoblastic disease and other hCG-producing cancers.
The Journal of reproductive medicine 2006;51(10):793-811.
2006: Laurence A Cole; Donghai Dai; Stephen Butler; Kimberly K Leslie; Ernest I Kohorn
Gestational trophoblastic diseases: 1. Pathophysiology of hyperglycosylated hCG.
Gynecologic oncology 2006;102(2):145-50.
2006: Laurence A Cole; Sarah A Khanlian; Carolyn Y Muller; Almareena Giddings; Ernest I Kohorn; Ross Berkowitz
Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
Gynecologic oncology 2006;102(2):160-4.
2006: Laurence A Cole; Sarah A Khanlian; Almareena Giddings; Stephen Butler; Carolyn Y Muller; Charles Hammond; Ernest I Kohorn
Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
Gynecologic oncology 2006;102(2):165-72.
2006: Laurence A Cole; Stephen Butler; Sarah A Khanlian; Almareena Giddings; Carolyn Y Muller; Michael J Seckl; Ernest I Kohorn
Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
Gynecologic oncology 2006;102(2):151-9.
2005: Harriet O Smith; Ernest I Kohorn; Laurence A Cole
Choriocarcinoma and gestational trophoblastic disease.
Obstetrics and gynecology clinics of North America 2005;32(4):661-84.
2005: Laurence A Cole; Ernest I Kohorn; Harriet O Smith
Gestation trophoblastic diseases: management of cases with persistent low human chorionic gonadotropin results.
Obstetrics and gynecology clinics of North America 2005;32(4):615-26.
2004: Ernest I Kohorn
Practice bulletin No. 53--Diagnosis and treatment of gestational trophoblastic disease.
Obstetrics and gynecology 2004;104(6):1422; author reply 1422-3.
2004: Robin M Masheb; Christine Lozano-Blanco; Ernest I Kohorn; Mary Jane Minkin; Robert D Kerns
Assessing sexual function and dyspareunia with the Female Sexual Function Index (FSFI) in women with vulvodynia.
Journal of sex & marital therapy 2004;30(5):315-24.
2004: Ernest I Kohorn
What we know about low-level hCG: definition, classification and management.
The Journal of reproductive medicine 2004;49(6):433-7.
2004: Stephen B Young; Ernest I Kohorn; Susan Braz-Martin; Stephen Baker
A survey of the complications of vaginal prolapse surgery performed by members of the Society Of Gynecologic Surgeons.
International urogynecology journal and pelvic floor dysfunction 2004;15(3):165-70.
2004: Ernest I Kohorn
Problems with nomenclature and pharmacodynamics in trophoblastic disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(1):203-4; author reply 204.
2003: Ernest I Kohorn
Human chorionic gonadotropin follow-up in patients with molar pregnancy: a time for reevaluation.
Obstetrics and gynecology 2003;102(6):1417.
2003: Ernest I Kohorn
How ultrasound first came to new England.
The Yale journal of biology and medicine 2003;76(4-6):155-61.
2002: Ernest I Kohorn
Negotiating a staging and risk factor scoring system for gestational trophoblastic neoplasia. A progress report.
The Journal of reproductive medicine 2002;47(6):445-50.
2002: Ernest I Kohorn
Gestational trophoblastic neoplasia and evidence-based medicine.
The Journal of reproductive medicine 2002;47(6):427-32.
2002: Ernest I Kohorn
Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma.
Gynecologic oncology 2002;85(2):315-20.
2002: Ernest I Kohorn
Is lack of response to single-agent chemotherapy in gestational trophoblastic disease associated with dose scheduling or chemotherapy resistance?
Gynecologic oncology 2002;85(1):36-9.
2001: Ernest I Kohorn; Barry M Kacinski; E Richard Stanley
Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
Gynecologic oncology 2001;80(3):383-6.
2001: Ernest I Kohorn
The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: description and critical assessment.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2001;11(1):73-7.
2000: Ernest I Kohorn
Measurement of CA-125 in trophoblastic disease.
Gynecologic oncology 2000;78(1):39-42.
1999: Masoud Azodi; Setsuko K Chambers; Thomas Rutherford; Ernest I Kohorn; Peter E Schwartz; Joseph T Chambers
Adenocarcinoma in situ of the cervix: management and outcome.
Gynecologic oncology 1999;73(3):348-53.
1999: Peter E Schwartz; Thomas Rutherford; Joseph T Chambers; Ernest I Kohorn; R P Thiel
Neoadjuvant chemotherapy for advanced ovarian cancer: long-term survival.
Gynecologic oncology 1999;72(1):93-9.
1998: Kunle Odunsi; L L Peck; Ernest I Kohorn; Vinita Parkash; Bernadette Cracchiolo; Joseph T Chambers; Kenneth J W Taylor
Necrosis of myometrial choriocarcinoma with fulminating sepsis complicating chemotherapy for trophoblastic tumor.
Gynecologic oncology 1998;70(1):100-4.
1998: FV Price; Setsuko K Chambers; Maria Luisa Carcangiu; Ernest I Kohorn; Peter E Schwartz; Joseph T Chambers
CA 125 may not reflect disease status in patients with uterine serous carcinoma.
Cancer 1998;82(9):1720-5.
1998: Ernest I Kohorn
Staging and assessing trophoblastic tumors. A possible solution to an intractable problem.
The Journal of reproductive medicine 1998;43(1):33-6.
1998: Ernest I Kohorn; Shirley M McCarthy; Kenneth J W Taylor
Nonmetastatic gestational trophoblastic neoplasia. Role of ultrasonography and magnetic resonance imaging.
The Journal of reproductive medicine 1998;43(1):14-20.
1998: Bruce C Turner; Jonathan Knisely; Barry M Kacinski; Bruce G Haffty; Andrew A Gumbs; Kenneth B Roberts; A H Frank; Richard E Peschel; Thomas Rutherford; B Edraki; Ernest I Kohorn; Setsuko K Chambers; Peter E Schwartz; Lynn D Wilson
Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.
International journal of radiation oncology, biology, physics 1998;40(1):77-84.
1997: Setsuko K Chambers; Joseph T Chambers; C A Davis; Ernest I Kohorn; Peter E Schwartz; M I Lorber; Robert E Handschumacher; Giuseppe Pizzorno
Pharmacokinetic and phase I trial of intraperitoneal carboplatin and cyclosporine in refractory ovarian cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(5):1945-52.
1996: Ernest I Kohorn
For what we stand.
American journal of obstetrics and gynecology 1996;175(6):1414-7.
1996: E Resnik; Setsuko K Chambers; Maria Luisa Carcangiu; Ernest I Kohorn; Peter E Schwartz; I T Chambers
Malignant uterine smooth muscle tumors: role of etoposide, cisplatin, and doxorubicin (EPA) chemotherapy.
Journal of surgical oncology 1996;63(3):145-7.
1996: Setsuko K Chambers; C A Davis; Peter E Schwartz; Ernest I Kohorn; Joseph T Chambers
Modulation of platinum sensitivity and resistance by cyclosporin A in refractory ovarian and fallopian tube cancer patients: a phase II study.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(10):1693-7.
1996: I Cass; E Resnik; Joseph T Chambers; Setsuko K Chambers; Maria Luisa Carcangiu; Ernest I Kohorn; Peter E Schwartz
Combination chemotherapy with etoposide, cisplatin, and doxorubicin in mixed müllerian tumors of the adnexa.
Gynecologic oncology 1996;61(3):309-14.
1996: D A Fishman; K B Roberts; Joseph T Chambers; Ernest I Kohorn; Peter E Schwartz; Setsuko K Chambers
Radiation therapy as exclusive treatment for medically inoperable patients with stage I and II endometrioid carcinoma with endometrium.
Gynecologic oncology 1996;61(2):189-96.
1996: Joseph T Chambers; Setsuko K Chambers; Ernest I Kohorn; Maria Luisa Carcangiu; Peter E Schwartz
Uterine papillary serous carcinoma treated with intraperitoneal cisplatin and intravenous doxorubicin and cyclophosphamide.
Gynecologic oncology 1996;60(3):438-42.
1995: E Resnik; Setsuko K Chambers; Maria Luisa Carcangiu; Ernest I Kohorn; Peter E Schwartz; Joseph T Chambers
A phase II study of etoposide, cisplatin, and doxorubicin chemotherapy in mixed müllerian tumors (MMT) of the uterus.
Gynecologic oncology 1995;56(3):370-5.
1995: Ernest I Kohorn
The trophoblastic Tower of Babel: classification systems for metastatic gestational trophoblastic neoplasia.
Gynecologic oncology 1995;56(2):280-8.
1995: D A Fishman; Setsuko K Chambers; Peter E Schwartz; Ernest I Kohorn; Joseph T Chambers
Extramammary Paget's disease of the vulva.
Gynecologic oncology 1995;56(2):266-70.
1995: Leslie Scoutt; Shirley M McCarthy; Stuart D Flynn; Robert C Lange; F Long; Robert C Smith; Setsuko K Chambers; Ernest I Kohorn; P Schwartz; Joseph T Chambers
Clinical stage I endometrial carcinoma: pitfalls in preoperative assessment with MR imaging. Work in progress.
Radiology 1995;194(2):567-72.
1994: M Rosman; C L Hayden; R P Thiel; Joseph T Chambers; Ernest I Kohorn; S K Chambers; Peter E Schwartz
Prognostic indicators for poor risk epithelial ovarian carcinoma.
Cancer 1994;74(4):1323-8.
1994: Setsuko K Chambers; L Lamb; Ernest I Kohorn; Peter E Schwartz; Joseph T Chambers
Chemotherapy of recurrent/advanced cervical cancer: results of the Yale University PBM-PFU protocol.
Gynecologic oncology 1994;53(2):161-9.
1994: Laurence A Cole; Ernest I Kohorn; G S Kim
Detecting and monitoring trophoblastic disease. New perspectives on measuring human chorionic gonadotropin levels.
The Journal of reproductive medicine 1994;39(3):193-200.
1993: FV Price; Setsuko K Chambers; Maria Luisa Carcangiu; Ernest I Kohorn; Peter E Schwartz; Joseph T Chambers
Intravenous cisplatin, doxorubicin, and cyclophosphamide in the treatment of uterine papillary serous carcinoma (UPSC).
Gynecologic oncology 1993;51(3):383-9.
1993: Ernest I Kohorn
Plasma methotrexate levels in patients receiving etoposide, methotrexate, actinomycin, cyclophosphamide, and vincristine (EMA-CO) chemotherapy for trophoblastic neoplasia.
Gynecologic oncology 1993;50(3):300-4.
1993: Ernest I Kohorn
The Department of Obstetrics and Gynecology at Yale: the first one hundred fifty years, from Nathan Smith to Lee Buxton.
The Yale journal of biology and medicine 1993;66(2):85-105.
1993: FV Price; Setsuko K Chambers; Joseph T Chambers; Maria Luisa Carcangiu; Peter E Schwartz; Ernest I Kohorn; E Richard Stanley; Barry M Kacinski
Colony-stimulating factor-1 in primary ascites of ovarian cancer is a significant predictor of survival.
American journal of obstetrics and gynecology 1993;168(2):520-7.
1993: Ernest I Kohorn
Evaluation of the criteria used to make the diagnosis of nonmetastatic gestational trophoblastic neoplasia.
Gynecologic oncology 1993;48(2):139-47.
1993: J W Barton; Shirley M McCarthy; Ernest I Kohorn; Leslie Scoutt; Robert C Lange
Pelvic MR imaging findings in gestational trophoblastic disease, incomplete abortion, and ectopic pregnancy: are they specific?
Radiology 1993;186(1):163-8.
1991: A H Frank; P C Tseng; Bruce G Haffty; D P Papadopoulos; Barry M Kacinski; S W Dowling; Maria Luisa Carcangiu; Ernest I Kohorn; Joseph T Chambers; Setsuko K Chambers
Adjuvant whole-abdominal radiation therapy in uterine papillary serous carcinoma.
Cancer 1991;68(7):1516-9.
1991: Ernest I Kohorn
Surgery for stress urinary incontinence.
Current opinion in obstetrics & gynecology 1991;3(3):394-7.
1991: Ernest I Kohorn
Single-agent chemotherapy for nonmetastatic gestational trophoblastic neoplasia. Perspectives for the 21st century after three decades of use.
The Journal of reproductive medicine 1991;36(1):49-55.
1989: Ernest I Kohorn
The surgery of stress urinary incontinence.
Obstetrics and gynecology clinics of North America 1989;16(4):841-52.
1989: Barry M Kacinski; E Richard Stanley; Darryl L Carter; Joseph T Chambers; Setsuko K Chambers; Ernest I Kohorn; Peter E Schwartz
Circulating levels of CSF-1 (M-CSF) a lymphohematopoietic cytokine may be a useful marker of disease status in patients with malignant ovarian neoplasms.
International journal of radiation oncology, biology, physics 1989;17(1):159-64.
1989: Barry M Kacinski; Darryl L Carter; Ernest I Kohorn; K Mittal; R S Bloodgood; J Donahue; C A Kramer; D Fischer; R Edwards; Setsuko K Chambers
Oncogene expression in vivo by ovarian adenocarcinomas and mixed-mullerian tumors.
The Yale journal of biology and medicine 1989;62(4):379-92.
1989: Peter E Schwartz; Joseph T Chambers; Ernest I Kohorn; Setsuko K Chambers; H Weitzman; I M Voynick; N MacLusky; Frederick Naftolin
Tamoxifen in combination with cytotoxic chemotherapy in advanced epithelial ovarian cancer. A prospective randomized trial.
Cancer 1989;63(6):1074-8.
1989: C Kramer; Richard E Peschel; N Goldberg; Ernest I Kohorn; Joseph T Chambers; Setsuko K Chambers; Peter E Schwartz
Radiation treatment of FIGO stage IVA carcinoma of the cervix.
Gynecologic oncology 1989;32(3):323-6.
1988: Joseph T Chambers; M J Merino; Ernest I Kohorn; Peter E Schwartz
Borderline ovarian tumors.
American journal of obstetrics and gynecology 1988;159(5):1088-94.
1988: Barry M Kacinski; Darryl L Carter; K Mittal; Ernest I Kohorn; R S Bloodgood; J Donahue; L Donofrio; R Edwards; Peter E Schwartz; Joseph T Chambers
High level expression of fms proto-oncogene mRNA is observed in clinically aggressive human endometrial adenocarcinomas.
International journal of radiation oncology, biology, physics 1988;15(4):823-9.
1988: Joseph T Chambers; N MacLusky; A Eisenfield; Ernest I Kohorn; R Lawrence; Peter E Schwartz
Estrogen and progestin receptor levels as prognosticators for survival in endometrial cancer.
Gynecologic oncology 1988;31(1):65-81.
1988: Ernest I Kohorn
Hysteroscopy in the management of endometrial cancer.
Obstetrics and gynecology clinics of North America 1988;15(1):73-5.
1987: Kenneth J W Taylor; Peter E Schwartz; Ernest I Kohorn
Gestational trophoblastic neoplasia: diagnosis with Doppler US.
Radiology 1987;165(2):445-8.
1987: Ernest I Kohorn
Nonmetastatic gestational trophoblastic neoplasia. Controversies in definition and management.
The Journal of reproductive medicine 1987;32(9):644-51.